Financhill
Back

BioXcel Therapeutics Stock Predictions

Sell
2

BTAI
BioXcel Therapeutics

Last Price:
1.86
Seasonality Move:
-27.59%

7 Day Trial

ALL ACCESS PASS

$ 7

BioXcel Therapeutics Stock Forecast

  • Is BioXcel Therapeutics Stock Undervalued?
    The current BioXcel Therapeutics [BTAI] share price is $1.86. The Score for BTAI is 2, which is 96% below its historic median score of 50, and infers higher risk than normal.
  • BTAI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will BioXcel Therapeutics Stock Go Up Next Year?

Data Unavailable

BioXcel Therapeutics Stock Rating

Data Unavailable

BioXcel Therapeutics Stock Price History

Is BTAI stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bioxceltherapeutics.com

52-Week Data

52-Week High:
22.06
52-Week Low:
1.79

Prediction Charts

Market Cap:
69.81M
Price in USD:
1.86
Volume:
553.04K
Beta:
0.90

Technical Analysis

SMA50:
2.53
SMA100:
2.78
SMA200:
3.17
52-Wk Change:
-92.83%

Stock Predictions

  • Is BioXcel Therapeutics stock public?
    Yes, BioXcel Therapeutics is a publicly traded company.
  • What is the BioXcel Therapeutics stock quote today?
    The BioXcel Therapeutics stock price is 1.86 USD today.
  • How to buy BioXcel Therapeutics stock online?
    You can buy BioXcel Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-7 2.50 2.37 2.58 2.34
May-8 2.36 2.12 2.37 2.10
May-9 2.28 2.31 2.45 2.20
May-10 2.32 2.09 2.33 2.05
May-13 2.15 2.19 2.22 2.14
May-14 2.20 2.13 2.29 2.08
May-15 2.18 2.06 2.23 2.06
May-16 2.14 2.09 2.15 2.05
May-17 2.10 2.07 2.19 2.06
May-20 2.08 2.10 2.12 1.99
May-21 2.10 2.01 2.10 1.99
May-22 1.97 1.97 2.04 1.95
May-23 1.98 1.85 1.99 1.85
May-24 1.88 1.86 1.88 1.79

BioXcel Therapeutics Earnings

Data Unavailable

BioXcel Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.65 per share, an increase next quarter of $0.18 per share, an increase this year of $3.38 per share, and an increase next year of $0.97 per share.

* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.